CFON-026
CFON-026 is a selective, orally active, non-covalent BTK inhibitor with an IC50 of 0.27 nM. It demonstrates significant antitumor activity against wild-type BTK (TMD8 and REC-1) as well as all clinically relevant BTK resistance mutations (BTKC481S, T474I, L528W, and V416L) . CFON-026 induces complete tumor regression in the TMD8 xenograft mouse model. This compound is applicable for research into hematologic cancers, such as chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
Product Specifications
CAS Number
2941611-57-8
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
NC=1C=2N3C ([C@]4 (C[C@] (NC (=O) CCCCC\C=C\C3=CN1) (CCC4) [H]) [H]) =NC2C5=CC=C (C (NC6=CC (C#N) =CC=N6) =O) C=C5
Molecular Formula
C33H34N8O2
Molecular Weight
574.68
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
